# Deckers Outdoor Corp: financial statements, quarterly

DECK · NYSE · CIK 910521 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/deck.md) · [Financials](/companies/deck/financials.md) · [Filings](/companies/deck/filings.md) · [Insiders](/companies/deck/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/deck/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,092](/filings/0000910521-24-000059.md) | [1,560](/filings/0000910521-25-000005.md) | [960](/filings/0000910521-24-000017.md) | [825](/filings/0000910521-25-000037.md) | [1,311](/filings/0000910521-25-000044.md) | [1,827](/filings/0000910521-26-000005.md) | [1,022 d](/filings/0001628280-26-037664.md) | [965](/filings/0000910521-26-000022.md) | [1,431](/filings/0000910521-25-000044.md) | [1,958](/filings/0000910521-26-000005.md) | [1,119 d](/filings/0001628280-26-037664.md) | [1,020](/filings/0000910521-26-000022.md) |
| Cost of revenue | $m | [509](/filings/0000910521-24-000059.md) | [644](/filings/0000910521-25-000005.md) | [420 d](/filings/0001628280-26-037664.md) | [355](/filings/0000910521-25-000037.md) | [578](/filings/0000910521-25-000044.md) | [725](/filings/0000910521-26-000005.md) | [442 d](/filings/0001628280-26-037664.md) | [427](/filings/0000910521-26-000022.md) | [627](/filings/0000910521-25-000044.md) | [786](/filings/0000910521-26-000005.md) | [475 d](/filings/0001628280-26-037664.md) | [444](/filings/0000910521-26-000022.md) |
| Gross profit | $m | [583](/filings/0000910521-24-000059.md) | [917](/filings/0000910521-25-000005.md) | [539](/filings/0000910521-24-000017.md) | [470](/filings/0000910521-25-000037.md) | [733](/filings/0000910521-25-000044.md) | [1,103](/filings/0000910521-26-000005.md) | [580 d](/filings/0001628280-26-037664.md) | [538](/filings/0000910521-26-000022.md) | [804](/filings/0000910521-25-000044.md) | [1,171](/filings/0000910521-26-000005.md) | [645 d](/filings/0001628280-26-037664.md) | [575](/filings/0000910521-26-000022.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [358](/filings/0000910521-24-000059.md) | [429](/filings/0000910521-25-000005.md) | [395 d](/filings/0001628280-26-037664.md) | [337](/filings/0000910521-25-000037.md) | [428](/filings/0000910521-25-000044.md) | [535](/filings/0000910521-26-000005.md) | [406 d](/filings/0001628280-26-037664.md) | [373](/filings/0000910521-26-000022.md) | [477](/filings/0000910521-25-000044.md) | [557](/filings/0000910521-26-000005.md) | [488 d](/filings/0001628280-26-037664.md) | [420](/filings/0000910521-26-000022.md) |
| Operating income | $m | [225](/filings/0000910521-24-000059.md) | [488](/filings/0000910521-25-000005.md) | [144](/filings/0000910521-24-000017.md) | [133](/filings/0000910521-25-000037.md) | [305](/filings/0000910521-25-000044.md) | [567](/filings/0000910521-26-000005.md) | [174 d](/filings/0001628280-26-037664.md) | [165](/filings/0000910521-26-000022.md) | [327](/filings/0000910521-25-000044.md) | [614](/filings/0000910521-26-000005.md) | [157 d](/filings/0001628280-26-037664.md) | [155](/filings/0000910521-26-000022.md) |
| Interest expense | $m | [1.0](/filings/0000910521-24-000059.md) | [0.9](/filings/0000910521-25-000005.md) | [(0.4) d](/filings/0001628280-26-037664.md) | [1.0](/filings/0000910521-25-000037.md) | [1.2](/filings/0000910521-25-000044.md) | [0.6](/filings/0000910521-26-000005.md) | [0.7 d](/filings/0001628280-26-037664.md) | [0.9](/filings/0000910521-26-000022.md) | [0.5](/filings/0000910521-25-000044.md) | [1.1](/filings/0000910521-26-000005.md) | [0.0 d](/filings/0001628280-26-037664.md) | [2.2](/filings/0000910521-26-000022.md) |
| Income tax | $m | [55.8](/filings/0000910521-24-000059.md) | [109](/filings/0000910521-25-000005.md) | [36.7 d](/filings/0001628280-26-037664.md) | [33.5](/filings/0000910521-25-000037.md) | [76.6](/filings/0000910521-25-000044.md) | [127](/filings/0000910521-26-000005.md) | [39.9 d](/filings/0001628280-26-037664.md) | [43.9](/filings/0000910521-26-000022.md) | [74.2](/filings/0000910521-25-000044.md) | [146](/filings/0000910521-26-000005.md) | [38.5 d](/filings/0001628280-26-037664.md) | [39.1](/filings/0000910521-26-000022.md) |
| Net income | $m | [179](/filings/0000910521-25-000005.md) | [390](/filings/0000910521-25-000005.md) | [128](/filings/0000910521-24-000017.md) | [116](/filings/0000910521-26-000005.md) | [242](/filings/0000910521-26-000005.md) | [457](/filings/0000910521-26-000005.md) | [151 d](/filings/0001628280-26-037664.md) | [139](/filings/0000910521-26-000022.md) | [268](/filings/0000910521-26-000005.md) | [481](/filings/0000910521-26-000005.md) | [136 d](/filings/0001628280-26-037664.md) | [130](/filings/0000910521-26-000022.md) |
| Diluted EPS | $ per share | [1.14](/filings/0000910521-24-000059.md) | [2.52](/filings/0000910521-25-000005.md) | [4.95](/filings/0000910521-24-000017.md) | [0.75](/filings/0000910521-25-000037.md) | [1.59](/filings/0000910521-25-000044.md) | [3.00](/filings/0000910521-26-000005.md) | not reported | [0.93](/filings/0000910521-26-000022.md) | [1.82](/filings/0000910521-25-000044.md) | [3.33](/filings/0000910521-26-000005.md) | not reported | [0.94](/filings/0000910521-26-000022.md) |
| Basic EPS | $ per share | [1.14](/filings/0000910521-24-000059.md) | [2.53](/filings/0000910521-25-000005.md) | [4.98](/filings/0000910521-24-000017.md) | [0.76](/filings/0000910521-25-000037.md) | [1.59](/filings/0000910521-25-000044.md) | [3.01](/filings/0000910521-26-000005.md) | not reported | [0.93](/filings/0000910521-26-000022.md) | [1.82](/filings/0000910521-25-000044.md) | [3.34](/filings/0000910521-26-000005.md) | not reported | [0.94](/filings/0000910521-26-000022.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [823](/filings/0000910521-23-000042.md) | [1,651](/filings/0000910521-24-000007.md) | [1,502](/filings/0000910521-25-000017.md) | [1,438](/filings/0000910521-24-000042.md) | [1,226](/filings/0000910521-24-000059.md) | [2,241](/filings/0000910521-25-000005.md) | [1,889](/filings/0001628280-26-037664.md) | [1,720](/filings/0000910521-25-000037.md) | [1,414](/filings/0000910521-25-000044.md) | [2,087](/filings/0000910521-26-000005.md) | [1,907](/filings/0000910521-26-000022.md) | [1,603](/filings/0000910521-26-000022.md) |
| Current assets | $m | [2,180](/filings/0000910521-23-000042.md) | [2,649](/filings/0000910521-24-000007.md) | [2,443](/filings/0000910521-25-000017.md) | [2,613](/filings/0000910521-24-000042.md) | [2,701](/filings/0000910521-24-000059.md) | [3,274](/filings/0000910521-25-000005.md) | [2,860](/filings/0001628280-26-037664.md) | [3,075](/filings/0000910521-25-000037.md) | [2,971](/filings/0000910521-25-000044.md) | [3,282](/filings/0000910521-26-000005.md) | [2,850](/filings/0000910521-26-000022.md) | [2,922](/filings/0000910521-26-000022.md) |
| Total assets | $m | [2,849](/filings/0000910521-23-000042.md) | [3,347](/filings/0000910521-24-000007.md) | [3,136](/filings/0000910521-25-000017.md) | [3,306](/filings/0000910521-24-000042.md) | [3,398](/filings/0000910521-24-000059.md) | [3,964](/filings/0000910521-25-000005.md) | [3,570](/filings/0001628280-26-037664.md) | [3,839](/filings/0000910521-25-000037.md) | [3,784](/filings/0000910521-25-000044.md) | [4,102](/filings/0000910521-26-000005.md) | [3,688](/filings/0000910521-26-000022.md) | [3,869](/filings/0000910521-26-000022.md) |
| Current liabilities | $m | [759](/filings/0000910521-23-000042.md) | [927](/filings/0000910521-24-000007.md) | [720](/filings/0000910521-25-000017.md) | [912](/filings/0000910521-24-000042.md) | [876](/filings/0000910521-24-000059.md) | [1,033](/filings/0000910521-25-000005.md) | [770](/filings/0001628280-26-037664.md) | [1,047](/filings/0000910521-25-000037.md) | [969](/filings/0000910521-25-000044.md) | [1,149](/filings/0000910521-26-000005.md) | [804](/filings/0000910521-26-000022.md) | [1,064](/filings/0000910521-26-000022.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,795](/filings/0000910521-25-000005.md) | [2,104](/filings/0000910521-25-000005.md) | [2,107](/filings/0001628280-26-037664.md) | [2,074](/filings/0000910521-26-000005.md) | [2,223](/filings/0000910521-26-000005.md) | [2,631](/filings/0000910521-26-000005.md) | [2,513](/filings/0000910521-26-000022.md) | [2,467](/filings/0000910521-26-000022.md) | [2,466](/filings/0000910521-26-000005.md) | [2,609](/filings/0000910521-26-000005.md) | [2,500](/filings/0000910521-26-000022.md) | [2,302](/filings/0000910521-26-000022.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.7) d](/filings/0000910521-24-000059.md) | [940 d](/filings/0000910521-25-000005.md) | [(28.7) d](/filings/0001628280-26-037664.md) | [113](/filings/0000910521-25-000037.md) | [(90.6) d](/filings/0000910521-25-000044.md) | [1,095 d](/filings/0000910521-26-000005.md) | [(73.0) d](/filings/0001628280-26-037664.md) | [36.1](/filings/0000910521-26-000022.md) | [8.1 d](/filings/0000910521-25-000044.md) | [1,042 d](/filings/0000910521-26-000005.md) | [95.8 d](/filings/0001628280-26-037664.md) | [47.9](/filings/0000910521-26-000022.md) |
| Capital expenditure | $m | [26.7 d](/filings/0000910521-24-000059.md) | [16.6 d](/filings/0000910521-25-000005.md) | [15.3 d](/filings/0001628280-26-037664.md) | [22.5](/filings/0000910521-25-000037.md) | [22.8 d](/filings/0000910521-25-000044.md) | [24.4 d](/filings/0000910521-26-000005.md) | [16.4 d](/filings/0001628280-26-037664.md) | [23.9](/filings/0000910521-26-000022.md) | [22.0 d](/filings/0000910521-25-000044.md) | [21.6 d](/filings/0000910521-26-000005.md) | [17.1 d](/filings/0001628280-26-037664.md) | [15.2](/filings/0000910521-26-000022.md) |
| Share repurchases | $m | [185 d](/filings/0000910521-24-000059.md) | [99.7 d](/filings/0000910521-25-000005.md) | [104 d](/filings/0001628280-26-037664.md) | [152](/filings/0000910521-25-000037.md) | [104 d](/filings/0000910521-25-000044.md) | [44.7 d](/filings/0000910521-26-000005.md) | [266 d](/filings/0001628280-26-037664.md) | [183](/filings/0000910521-26-000022.md) | [282 d](/filings/0000910521-25-000044.md) | [349 d](/filings/0000910521-26-000005.md) | [262 d](/filings/0001628280-26-037664.md) | [338](/filings/0000910521-26-000022.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.7](/filings/0000910521-23-000042.md) | [26.6](/filings/0000910521-24-000007.md) | [26.3](/filings/0000910521-24-000042.md) | [157](/filings/0000910521-24-000059.md) | [155](/filings/0000910521-25-000005.md) | [153](/filings/0000910521-25-000037.md) | [153](/filings/0000910521-25-000044.md) | [152](/filings/0000910521-26-000005.md) | [150](/filings/0000910521-26-000022.md) | [148](/filings/0000910521-25-000044.md) | [144](/filings/0000910521-26-000005.md) | [139](/filings/0000910521-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 136,414,227 at 2026-07-09, from the cover of the [10-Q filed 2026-07-30](/filings/0000910521-26-000022.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.